Current Monje Lab Members

 

 

Michelle Monje, MD, PhD

Michelle Monje, MD, PhD is a Professor of Neurology and Neurological Sciences and a Howard Hughes Medical Institute Investigator.   Her research program focuses at the intersection of neuroscience and brain cancer biology, with a particular focus on mechanisms and consequences of neuron-glial interactions in health, glial dysfunction in neurological disease and neuron-glial interactions in malignant glioma. Together with these basic studies, her research program has advanced preclinical studies of novel therapeutics for pediatric high-grade gliomas and cancer therapy-related cognitive impairment in order to translate new therapies to the clinic. 

Gabrielle Devienne, PhD

Gabrielle Devienne completed her PhD in France and is currently a research scientist working in both the Monje Lab and Huguenard’s lab. Her work uses electrophysiology across multiple scales to study how neural development and circuit function are shaped and disrupted in disease. Outside the lab, she enjoys playing with her toddler, climbing, surfing, and exploring Japanese culture.

Avishai Gavish, MD, PhD

Avishai is a seasoned scientist with extensive experience in academia and healthcare. Currently a Senior Scientist at Stanford University, he has held significant roles at the Weizmann Institute of Science and MetaSight Diagnostics. His expertise spans scientific research and medical affairs, supported by a robust educational background with an MD from Tel Aviv University and a PhD in Computational Biology from the Weizmann Institute.

Anna Geraghty, PhD

Anna is a senior staff scientist in the department of neurology and neurological sciences at Stanford University. She received her doctorate degree in the Integrative Biology department at UC Berkeley. She specialized in neuroendocrinology, investigating how chronic stress inhibited hypothalamic neural circuit regulation of reproduction in rodents using a combination of molecular and behavioral techniques. Currently her research focuses on developing CAR T-cell therapies for pediatric brain tumors and researching the repercussions of CAR T-cell induced neuroinflammation after therapy on the brain microenvironment and cognition.

Belgin Yalcin, PhD

Belgin received her PhD from the University of Cambridge in 2016, after completing an undergraduate degree in Molecular Biology and Genetics at Istanbul Technical University in 2011. In the Monje lab, her research focuses on understanding myelin plasticity of the brain. Specifically, she is investigating the basis of heterogeneity in the response of myelin-forming cells to neuronal activity.